Company
Mosanna Therapeutics
- Biotech
- Location:
- Basel, Switzerland
Description
Mosanna Therapeutics develops a nighttime nasal spray that pharmacologically reactivates upper airway muscles to reduce airway collapse during sleep, targeting obstructive sleep apnea with a device-free pharmaceutical approach integrated into bedtime routines.
Related
NeurovalensNeurovalens develops noninvasive neurostimulation products, including Modius Sleep, an FDA-cleared neurostimulator device used…
Jazz PharmaceuticalsJazz Pharmaceuticals develops and commercializes medicines for people with rare diseases, focusing on therapies for epilepsies, cancers and…
Engimmune Therapeutics AGEngimmune Therapeutics AG engineers soluble T‑cell receptor (TCR) therapeutics using AI‑guided protein engineering to create multispecific,…
BachemBachem provides peptide and oligonucleotide development and GMP manufacturing services (CDMO) for pharmaceutical and biotechnology…
Windward BioWindward Bio engineers ultra-long-acting monoclonal antibodies, advancing WIN378 and WIN027 through clinical trials to reduce dosing…
Neurent MedicalNeurent Medical develops the NEUROMARK System, a radiofrequency-based ENT medical device that targets posterior nasal nerves to provide…
- Noema PharmaNoema Pharma processes and manages personal data collected via its website to respond to inquiries, consider employment applications,…
FIRE1FIRE1 develops NORM, an investigational heart failure management system that combines an implanted sensor in the inferior vena cava with a…
Aukera Therapeutics GmbHAukera Therapeutics GmbH develops the first RAPTOR inhibitors, using an AI-driven drug discovery platform and mTOR biology expertise to…